Gentian Diagnostics ASA (FRA:6FK)

Germany flag Germany · Delayed Price · Currency is EUR
4.600
-0.030 (-0.65%)
At close: Dec 5, 2025
37.72%
Market Cap 71.84M
Revenue (ttm) 14.72M
Net Income (ttm) 3.65M
Shares Out n/a
EPS (ttm) 0.23
PE Ratio 19.68
Forward PE 52.82
Dividend 0.03 (0.74%)
Ex-Dividend Date May 7, 2025
Volume n/a
Average Volume n/a
Open 4.600
Previous Close 4.630
Day's Range 4.600 - 4.600
52-Week Range 3.200 - 5.420
Beta n/a
RSI 50.48
Earnings Date Feb 11, 2026

About Gentian Diagnostics ASA

Gentian Diagnostics ASA develops, manufactures, and sells biochemical reagents for use in medical diagnostics and research in the United States, Asia, and Europe. The company offers in-vitro diagnostic reagents for clinical chemistry analyzers, such as Gentian Circulating Calprotectin Immunoassay, a turbidimetric assay used for the measurement of calprotectin in plasma and serum for detection and assessment of inflammation; Gentian Cystatin C Immunoassay test kit, a GFR marker for the diagnosis and therapeutic control of renal function and chro... [Read more]

Industry In Vitro and In Vivo Diagnostic Substances
Founded 2001
Employees 63
Stock Exchange Frankfurt Stock Exchange
Ticker Symbol 6FK
Full Company Profile

Financial Performance

Financial numbers in NOK Financial Statements

News

There is no news available yet.